BenchSci
BenchSci is offering a 4-month contract internship in Toronto for students pursuing a degree in Computer Science or Software Engineering. You will join a team of engineers to contribute to the company's mission of accelerating drug discovery and to gain hands-on experience in real-world software development. This onsite internship includes mentorship, collaboration, and opportunities to develop higher-level skills while making a tangible impact.
BenchSci develops EMET, an agentic AI workbench purpose-built for preclinical R&D that unifies proprietary scientific data, AI models, and workflows to help scientists reason through complex disease biology. EMET provides access to 16M+ closed-access papers, a proprietary knowledge graph with 858M nodes, and curated biological records across antibodies, RNAi, CRISPR, and more — enabling hypothesis generation, target identification, experiment design, and lead optimization. Pharma, biotech, and academic teams use BenchSci's EMET platform to accelerate drug discovery, reduce research fragmentation, and improve the accuracy of preclinical decision-making.
Sanofi inks pact with Canadian tech company to bring AI to preclinical R&D
Oct 8, 2025
BenchSci and Mila Partner to Advance AI for Biological Inference and Accelerate Drug Discovery
Nov 12, 2025
BenchSci signs license agreement with Sanofi for drug development platform
Oct 9, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for BenchSci.
7% below the average for this role
BenchSci Signs Three-Year Global License Agreement with Sanofi for ASCEND AI Platform
Oct 10, 2025